174 related articles for article (PubMed ID: 33425743)
21. Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Patients With Meningiomas.
Kuranari Y; Tamura R; Tsuda N; Kosugi K; Morimoto Y; Yoshida K; Toda M
Front Oncol; 2020; 10():592470. PubMed ID: 33330078
[TBL] [Abstract][Full Text] [Related]
22. Clinial Features, Individualized Treatment and Long-Term Surgical Outcomes of Skull Base Meningiomas With Extracranial Extensions.
Liu H; Qian H; Li X; Zuo F; Meng X; Liu S; Wan J
Front Oncol; 2020; 10():1054. PubMed ID: 32714869
[No Abstract] [Full Text] [Related]
23. Meta-analysis of adjuvant radiotherapy for intracranial atypical and malignant meningiomas.
Unterberger A; Nguyen T; Duong C; Kondajji A; Kulinich D; Yang I
J Neurooncol; 2021 Apr; 152(2):205-216. PubMed ID: 33635510
[TBL] [Abstract][Full Text] [Related]
24. High risk of recurrence for grade II meningioma: a 10-year multicenter analysis of prognosis factors.
Bender L; Somme F; Lhermitte B; Ahle G; Boone M; Blonski M; Pouget C; Truc G; Cebula H; Noël G
Chin Clin Oncol; 2021 Jun; 10(3):26. PubMed ID: 33752411
[TBL] [Abstract][Full Text] [Related]
25. World Health Organization Grade III (Nonanaplastic) Meningioma: Experience in a Series of 23 Cases.
Zhang GJ; Zhang GB; Zhang YS; Li H; Li CB; Zhang LW; Li D; Wu Z; Zhang JT
World Neurosurg; 2018 Apr; 112():e754-e762. PubMed ID: 29382616
[TBL] [Abstract][Full Text] [Related]
26. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.
Keric N; Kalasauskas D; Freyschlag CF; Gempt J; Misch M; Poplawski A; Lange N; Ayyad A; Thomé C; Vajkoczy P; Meyer B; Ringel F
J Neurooncol; 2020 Jan; 146(2):347-355. PubMed ID: 31900826
[TBL] [Abstract][Full Text] [Related]
27. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
Evers PD; Logan JE; Sills V; Chin AI
World J Urol; 2014 Apr; 32(2):385-91. PubMed ID: 23756991
[TBL] [Abstract][Full Text] [Related]
28. Survival Benefit of Adjuvant Radiotherapy in Elderly Patients with WHO Grade III Meningioma.
Zhou H; Bai HX; Chan L; Zhang PJ; Karakousis G; Huang R; Xiao B; Yang L
World Neurosurg; 2019 Nov; 131():e303-e311. PubMed ID: 31356979
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Characterization of Higher-Grade Meningiomas: A Histopathological Score to Predict Progression and Outcome.
Bertero L; Dalla Dea G; Osella-Abate S; Botta C; Castellano I; Morra I; Pollo B; Calatozzolo C; Patriarca S; Mantovani C; Rudà R; Tardivo V; Zenga F; Garbossa D; Papotti M; Soffietti R; Ricardi U; Cassoni P
J Neuropathol Exp Neurol; 2019 Mar; 78(3):248-256. PubMed ID: 30689922
[TBL] [Abstract][Full Text] [Related]
30. Atypical meningioma: a study of prognostic factors.
Zaher A; Abdelbari Mattar M; Zayed DH; Ellatif RA; Ashamallah SA
World Neurosurg; 2013 Nov; 80(5):549-53. PubMed ID: 23871812
[TBL] [Abstract][Full Text] [Related]
31. Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors.
Hollon T; Nguyen V; Smith BW; Lewis S; Junck L; Orringer DA
J Neurosurg; 2016 Aug; 125(2):410-8. PubMed ID: 26745489
[TBL] [Abstract][Full Text] [Related]
32. Survival impacts of extent of resection and adjuvant radiotherapy for the modern management of high-grade meningiomas.
Li D; Jiang P; Xu S; Li C; Xi S; Zhang J; Chen Y; Jiang X; Zhang X; Sai K; Wang J; Mou Y; Ke C; Chen Z
J Neurooncol; 2019 Oct; 145(1):125-134. PubMed ID: 31493161
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors for patients with World Health Organization grade III meningiomas treated at a single center.
Shan B; Zhang J; Song Y; Xu J
Medicine (Baltimore); 2017 Jun; 96(26):e7385. PubMed ID: 28658170
[TBL] [Abstract][Full Text] [Related]
34. Low Expression of Phosphatase and Tensin Homolog and High Expression of Ki-67 as Risk Factors of Prognosis in Cranial Meningiomas.
Ma J; Zhang Y; Chen L; Chen Y; Yang Y; Li D; Wang L; Zhang J; Wu Z
World Neurosurg; 2020 Apr; 136():e196-e203. PubMed ID: 31887465
[TBL] [Abstract][Full Text] [Related]
35. Long-Term Outcomes for Patients With Atypical or Malignant Meningiomas Treated With or Without Radiation Therapy: A 25-Year Retrospective Analysis of a Single-Institution Experience.
Kent CL; Mowery YM; Babatunde O; Wright AO; Barak I; McSherry F; Herndon JE; Friedman AH; Zomorodi A; Peters K; Desjardins A; Friedman H; Sperduto W; Kirkpatrick JP
Adv Radiat Oncol; 2022; 7(3):100878. PubMed ID: 35647401
[TBL] [Abstract][Full Text] [Related]
36. Long-Term Clinical Outcome of First Recurrence Skull Base Meningiomas.
Kuranari Y; Tamura R; Tsuda N; Kosugi K; Morimoto Y; Yoshida K; Toda M
J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31906133
[TBL] [Abstract][Full Text] [Related]
37. Early adjuvant radiotherapy in the treatment of atypical meningioma.
Jenkinson MD; Waqar M; Farah JO; Farrell M; Barbagallo GM; McManus R; Looby S; Hussey D; Fitzpatrick D; Certo F; Javadpour M
J Clin Neurosci; 2016 Jun; 28():87-92. PubMed ID: 26775147
[TBL] [Abstract][Full Text] [Related]
38. Differential Tumor Progression Patterns in Skull Base Versus Non-Skull Base Meningiomas: A Critical Analysis from a Long-Term Follow-Up Study and Review of Literature.
Savardekar AR; Patra DP; Bir S; Thakur JD; Mohammed N; Bollam P; Georgescu MM; Nanda A
World Neurosurg; 2018 Apr; 112():e74-e83. PubMed ID: 29258946
[TBL] [Abstract][Full Text] [Related]
39. WHO grade I meningiomas: classification-tree for prognostic factors of survival.
Lemée JM; Joswig H; Da Broi M; Corniola MV; Scheie D; Schaller K; Helseth E; Meling TR
Neurosurg Rev; 2020 Apr; 43(2):749-758. PubMed ID: 31183587
[TBL] [Abstract][Full Text] [Related]
40. Comparative genomic analysis of driver mutations in matched primary and recurrent meningiomas.
Loewenstern J; Rutland J; Gill C; Arib H; Pain M; Umphlett M; Kinoshita Y; McBride R; Donovan M; Sebra R; Bederson J; Fowkes M; Shrivastava R
Oncotarget; 2019 May; 10(37):3506-3517. PubMed ID: 31191822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
